Dr. Lipi Singh

Dr. Lipi Singh
Cell Therapist, Delhi


I am Dr. Lipi Singh, currently working in Advancells as Administrator/ Stem Cell Consultant in the field of Regenerative Medicine. Advancells Noida based Stem Cells Therapy Centre.


  • Cell Therapy

  • Aesthetic Dermatology

  • Arthritis

  • Bone Marrow Transplant

  • Burns surgery

  • Diabetic Foot Surgery

  • Dietetics

  • Sports Medicine


  • Administrator – Advancells
  • Stem cell consultant/scientist in the field of regenerative medicine


Practice Information

Advancells (Stem Cell Therapy), Noida

Advancells (Stem Cell Therapy), Noida

A-102/103, Sector - 5, Noida, Uttar Pradesh - 201301

Institute of Brain & Spine Hospital (IBS), Delhi

Institute of Brain & Spine Hospital (IBS), Delhi

73 Ring Road, Lajpat Nagar-3, Delhi, Delhi - 110024

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Lipi Singh and her staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • Stem cells: The New Age Remedy to Staying Young Naturally Dr. Lipi Singh, Chief Technology Officer , Advancells, New Delhi .Read More: http://bit.ly/2ap5a2A
  • http://www.advancells.com/stem-cells-the-new-age-remedy-to-staying-young-naturally-dr-lipi-singh-chief-technology-officer-advancells-new-delhi.php
  • http://www.apnnews.com/2016/04/04/stem-cells-the-new-age-remedy-to-staying-young-naturally-dr-lipi-singh-chief-technology-officer-advancells-new-delhi/


Liver disease is a growing health problem and one of the primary reasons of death worldwide. Hundreds of millions of patients are affected with liver problems globally. Among liver diseases, non alcoholic fatty liver as a severe form of liver disease and is one of the prominent liver diseases worldwide. Under favouring conditions, it might progress into liver cirrhosis and liver cancer, which in its end stage strongly requires organ transplantation. Referable to the scarcity of donor organs, unconventional therapeutic approaches are necessary. Further, the absence of an effective pharmacological therapy for fatty liver is a major motivator for research into new therapeutic approaches for fatty liver. Increased accumulation of fat in liver with subsequent derangements in liver functions is a common finding in patients with excess body fat.  Liver failure caused by non-alcoholic fatty liver disease (nafld) is now fetching one of the most common indications for liver transplantation. Fatty liver is a metabolic disease characterized by the incorporation of fat into hepatocytes. Initially, it is a benign condition, but it can progress to hepatitis, an inflammatory disease of the liver that can escort to fibrosis, cirrhosis, or even liver cancer.